A detailed history of Aft, Forsyth & Company, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 2,868 shares of ZTS stock, worth $507,521. This represents 0.28% of its overall portfolio holdings.

Number of Shares
2,868
Previous 2,941 2.48%
Holding current value
$507,521
Previous $509,000 10.02%
% of portfolio
0.28%
Previous 0.26%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $12,598 - $14,343
-73 Reduced 2.48%
2,868 $560,000
Q2 2024

Aug 13, 2024

SELL
$145.54 - $178.83 $57,488 - $70,637
-395 Reduced 11.84%
2,941 $509,000
Q1 2024

Apr 30, 2024

SELL
$165.67 - $199.94 $112,655 - $135,959
-680 Reduced 16.93%
3,336 $564,000
Q4 2023

Feb 09, 2024

SELL
$151.44 - $200.09 $30,288 - $40,018
-200 Reduced 4.74%
4,016 $792,000
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $14,484 - $16,760
-90 Reduced 2.09%
4,216 $726,000
Q1 2023

May 02, 2023

SELL
$145.48 - $175.02 $48,153 - $57,931
-331 Reduced 7.14%
4,306 $716,000
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $32,522 - $39,052
-248 Reduced 5.08%
4,637 $679,000
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $87,491 - $107,704
-590 Reduced 10.78%
4,885 $724,000
Q2 2022

Jul 28, 2022

SELL
$155.97 - $200.09 $7,798 - $10,004
-50 Reduced 0.9%
5,475 $941,000
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $9,684 - $12,351
-50 Reduced 0.9%
5,525 $1.35 Million
Q3 2021

Nov 08, 2021

BUY
$189.29 - $209.69 $40,697 - $45,083
215 Added 4.01%
5,575 $1.08 Million
Q2 2021

Jul 15, 2021

BUY
$155.9 - $187.99 $42,093 - $50,757
270 Added 5.3%
5,360 $999,000
Q1 2021

May 04, 2021

BUY
$144.0 - $169.39 $3,600 - $4,234
25 Added 0.49%
5,090 $802,000
Q4 2020

Feb 09, 2021

BUY
$157.07 - $174.35 $85,603 - $95,020
545 Added 12.06%
5,065 $838,000
Q3 2020

Nov 05, 2020

SELL
$137.1 - $165.37 $6,169 - $7,441
-45 Reduced 0.99%
4,520 $747,000
Q2 2020

Aug 06, 2020

BUY
$111.92 - $142.53 $43,648 - $55,586
390 Added 9.34%
4,565 $626,000
Q1 2020

May 11, 2020

BUY
$92.66 - $144.94 $3,243 - $5,072
35 Added 0.85%
4,175 $491,000
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $120,900 - $138,580
1,040 Added 33.55%
4,140 $548,000
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $348,967 - $398,133
3,100 New
3,100 $386,000
Q2 2019

Jul 29, 2019

SELL
$97.98 - $114.28 $278,753 - $325,126
-2,845 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$81.56 - $100.67 $4,893 - $6,040
60 Added 2.15%
2,845 $286,000
Q4 2018

Feb 05, 2019

BUY
$79.28 - $95.27 $634 - $762
8 Added 0.29%
2,785 $238,000
Q3 2018

Oct 26, 2018

BUY
$83.5 - $93.23 $6,262 - $6,992
75 Added 2.78%
2,777 $254,000
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $5,033 - $5,619
-63 Reduced 2.28%
2,702 $230,000
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $197,725 - $234,167
2,765 New
2,765 $231,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Aft, Forsyth & Company, Inc. Portfolio

Follow Aft, Forsyth & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aft, Forsyth & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aft, Forsyth & Company, Inc. with notifications on news.